» Articles » PMID: 39768245

Potential of Stem-Cell-Induced Peripheral Nerve Regeneration: From Animal Models to Clinical Trials

Overview
Journal Life (Basel)
Specialty Biology
Date 2025 Jan 8
PMID 39768245
Authors
Affiliations
Soon will be listed here.
Abstract

Peripheral nerve injury has become an increasingly prevalent clinical concern, causing great morbidity in the community. Although there have been significant advancements in the treatment of peripheral nerve damage in recent years, the issue of long-term nerve regeneration remains. Furthermore, Wallerian degeneration has created an obstacle to long-term nerve regeneration. For this reason, there has been extensive research on the use of exogenous and endogenous stem cells as an adjunct or even primary treatment option for peripheral nerve injury. The plasticity and inducibility of stem cells make them an enticing option for initiating neuronal cell regrowth and optimal sensory and functional nerve regeneration. Peripheral nerve injury has a broad range of causative factors and etiologies. As such, unique stem cell-induced peripheral nerve treatments are being investigated to ameliorate the damage incited by all causes, including trauma, neuropathy, and systemic neurodegenerative diseases. This review is oriented to outline the potential role of stem cell therapies in peripheral nerve injury versus the current standards of care, compare the benefits and drawbacks of specific stem cell lines under investigation, and highlight the current models of stem cell therapy in the peripheral nervous system, with the ultimate goal of narrowing down and optimizing the role and scope of stem cell therapy in peripheral nerve injury.

References
1.
Walsh S, Midha R . Practical considerations concerning the use of stem cells for peripheral nerve repair. Neurosurg Focus. 2009; 26(2):E2. DOI: 10.3171/FOC.2009.26.2.E2. View

2.
Amoh Y, Hamada Y, Aki R, Kawahara K, Hoffman R, Katsuoka K . Direct transplantation of uncultured hair-follicle pluripotent stem (hfPS) cells promotes the recovery of peripheral nerve injury. J Cell Biochem. 2010; 110(1):272-7. DOI: 10.1002/jcb.22534. View

3.
Tamez-Mata Y, Pedroza-Montoya F, Martinez-Rodriguez H, Garcia-Perez M, Rios-Cantu A, Gonzalez-Flores J . Nerve gaps repaired with acellular nerve allografts recellularized with Schwann-like cells: Preclinical trial. J Plast Reconstr Aesthet Surg. 2021; 75(1):296-306. DOI: 10.1016/j.bjps.2021.05.066. View

4.
Zhou L, Zhang J, Liu X, Zhou L . Co-Graft of Bone Marrow Stromal Cells and Schwann Cells Into Acellular Nerve Scaffold for Sciatic Nerve Regeneration in Rats. J Oral Maxillofac Surg. 2015; 73(8):1651-60. DOI: 10.1016/j.joms.2015.02.013. View

5.
Mozafari R, Kyrylenko S, Castro M, Ferreira Jr R, Barraviera B, Oliveira A . Combination of heterologous fibrin sealant and bioengineered human embryonic stem cells to improve regeneration following autogenous sciatic nerve grafting repair. J Venom Anim Toxins Incl Trop Dis. 2018; 24:11. PMC: 5897995. DOI: 10.1186/s40409-018-0147-x. View